13 results

External Validation of the Revised Pretransplant Assessment of Mortality Score in Allogeneic Hematopoietic Cell Transplantation: A Cohort Study

Fattinger, Nicolas; Roth, Jan A.; Baldomero, Helen; More

HemaSphere. 6(4):e704, April 2022.

Second Solid Cancers After Hematopoietic Stem Cell Transplantation: Active Surveillance During Long-term Follow-up

Lupo-Stanghellini, Maria Teresa; Piemontese, Simona; Assanelli, Andrea; More

HemaSphere. 5(11):e654, November 2021.

CD38-specific Chimeric Antigen Receptor Expressing Natural Killer KHYG-1 Cells: A Proof of Concept for an “Off the Shelf” Therapy for Multiple Myeloma

Stikvoort, Arwen; van der Schans, Jort; Sarkar, Subhashis; More

HemaSphere. 5(7):e596, July 2021.

Bone Marrow Mesenchymal Stromal Cell-mediated Resistance in Multiple Myeloma Against NK Cells can be Overcome by Introduction of CD38-CAR or TRAIL-variant

Holthof, Lisa C.; Stikvoort, Arwen; van der Horst, Hilma J.; More

HemaSphere. 5(5):e561, May 2021.

Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm

Baronciani, Donatella; Casale, Maddalena; De Franceschi, Lucia; More

HemaSphere. 5(5):e555, May 2021.

Clinicopathologic Findings in Fatal Neurotoxicity After Adoptive Immunotherapy With CD19-Directed CAR T-Cells

Karschnia, Philipp; Strübing, Felix; Teske, Nico; More

HemaSphere. 5(3):e533, March 2021.

Precision Medicine in Hematology 2021: Definitions, Tools, Perspectives, and Open Questions

Valent, Peter; Orfao, Alberto; Kubicek, Stefan; More

HemaSphere. 5(3):e536, March 2021.

Human Herpesvirus 6 Encephalitis Following Axicabtagene Ciloleucel Treatment for Refractory Diffuse Large B Cell Lymphoma

Shah, Mili; Kuhnl, Andrea; Shields, Gregory; More

HemaSphere. 5(3):e535, March 2021.

Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future

Heine, Renaud; Thielen, Frederick W.; Koopmanschap, Marc; More

HemaSphere. 5(2):e524, February 2021.